{"name":"BioCis Pharma Ltd","slug":"biocis-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cis-UCA 2.5% emulsion cream","genericName":"Cis-UCA 2.5% emulsion cream","slug":"cis-uca-2-5-emulsion-cream","indication":"Treatment of mild to moderate psoriasis","status":"phase_2"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cis-UCA 5% emulsion cream","genericName":"Cis-UCA 5% emulsion cream","slug":"cis-uca-5-emulsion-cream","indication":"Treatment of mild to moderate atopic dermatitis","status":"phase_2"}]}],"pipeline":[{"name":"Cis-UCA 2.5% emulsion cream","genericName":"Cis-UCA 2.5% emulsion cream","slug":"cis-uca-2-5-emulsion-cream","phase":"phase_2","mechanism":"Cis-UCA 2.5% emulsion cream is a topical treatment that works by reducing inflammation and modulating the immune response.","indications":["Treatment of mild to moderate psoriasis"],"catalyst":""},{"name":"Cis-UCA 5% emulsion cream","genericName":"Cis-UCA 5% emulsion cream","slug":"cis-uca-5-emulsion-cream","phase":"phase_2","mechanism":"Cis-UCA 5% emulsion cream is a topical treatment that works by reducing inflammation and modulating the immune response.","indications":["Treatment of mild to moderate atopic dermatitis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}